Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

Clinical trial NCT07576517 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07576517
Sponsor: Peking University First Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Older Patients Surgery Dexmedetomidine Esketamine Transcranial Direct Current Stimulation Perioperative Neurocognitive Disorders

Start date: 2026-06-01
Primary completion: 2029-06-01
Enrollment: 1160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.